The Cigna Group holds a leading position in the healthcare industry as a NYSE listed corporation. The company offers health insurance packages and associated medical services within the US borders. The organization divides its business into Evernorth Health Services and Cigna Healthcare sectors.
The stock reached $331.00 on April 1, 2025 with $89.74 billion market valuation. Professional market analysts strongly recommend buying Cigna stock with an average predicted return at $380.06.
Table of Contents
Our analysis helps investors make informed decisions by giving them comprehensive future predictions. These forecasts show upcoming results, forecast time horizons, market trends, possible investment returns and risk considerations. Every section presents information through validated data reports making results simpler to understand.
Key Metrics & Market Sentiment
The stock performance indicators show how well the business performs financially and how it stands in the market. The following table provides all necessary CI performance indicators in a single view.
| Metric | Value | Notes |
|---|---|---|
| Current Price | $331.00 | At close: April 1, 2025 |
| Market Cap | $89.74B | Indicates a large-cap company |
| Revenue (ttm) | $247.12B | Represents trailing twelve months revenue |
| Net Income (ttm) | $3.43B | Reflects profitability |
| EPS (ttm) | 12.12 | Earnings per share (trailing twelve months) |
| PE Ratio | 27.31 | Valuation measure |
| Forward PE | 11.14 | Valuation based on future earnings |
| Dividend | $6.04 (1.83% yield) | Dividend yield remains attractive |
| Beta | 0.53 | Indicates lower volatility than the market |
| Analyst Rating | Strong Buy | Consensus among 16 analysts |
| Price Target (12-month) | $380.06 | Average forecast price |
Market sentiment for CI is positive. The majority of analysts have maintained a “Strong Buy” stance. This reflects confidence in CI’s financial performance and its ability to capture future market share in healthcare. The low beta suggests that the stock has less price volatility compared to the overall market, an attractive factor for risk-averse investors.
Short-Term Price Predictions (2025) of CI Stock
Short-term forecasts assess the stock’s performance from five days up to one month. Analysts use technical data and fundamental events to support these predictions.
5-Day to 1-Month Forecast
The stock’s movement in the next few weeks is expected to be influenced by upcoming earnings announcements and dividend distributions. Here is a table that summarizes the short-term forecast:
| Time Horizon | Forecasted Price Range (USD) | Key Influences |
|---|---|---|
| 5-Day | $327.00 – $335.00 | Intra-week trading, market sentiment updates |
| 2-Week | $325.00 – $337.00 | Earnings expectations and analyst revisions |
| 1-Month | $323.00 – $340.00 | Short-term technical resistance and support levels |
Drivers Behind the Short-Term Forecast
Several factors drive the short-term price forecast:
- Earnings Announcements: An upcoming earnings release on May 1, 2025, will play a significant role. Positive EPS beats may push the price higher.
- Dividend Impact: The ex-dividend date on March 5, 2025, might create buying interest. Investors could factor the dividend yield of 1.83% into their trading strategies.
- Market Trends: CI’s current technical indicators, including its moving averages, support the notion of gradual price improvement. Momentum indicators and short-term analyst revisions add to this outlook.
- Overall Healthcare Sector Performance: The healthcare sector is projected to remain stable due to increased demand for services. This sector dynamic supports CI’s near-term performance.
Long-Term Price Predictions (2025–2030)
Long-term forecasts analyze CI’s prospects over a five-year span. This outlook takes into account macroeconomic factors, demographic shifts, and evolving regulatory environments.
Yearly Forecast Summary
Below is a projected summary table for the upcoming fiscal years based on analyst expectations and historical growth trends:
| Fiscal Year | Projected Revenue (B USD) | Projected EPS | Price Target (USD) |
|---|---|---|---|
| 2025 | 260.1 | 30.49 | 340 – 350 |
| 2026 | 273.2 | 34.03 | 350 – 360 |
| 2027 | 287.8 | 37.97 | 360 – 375 |
| 2028 | 300.0* | 40.00* | 375 – 390 |
| 2029 | 315.0* | 42.00* | 390 – 405 |
| 2030 | 330.0* | 44.00* | 405 – 420 |
*Figures for 2028–2030 are estimates based on recent trends and analyst projections.
Source: Yahoo Finance – CI
Long-Term Catalysts
Several long-term catalysts may boost CI’s stock performance:
- Demographic Trends: An aging population will require increased healthcare services. This drives demand for CI’s insurance and care management solutions.
- Regulatory Shifts: Changes in healthcare policy can affect revenue streams. New policies may lead to higher enrollment in CI’s plans.
- Technological Advances: CI continues to invest in technology to streamline operations. These investments can improve service delivery and reduce costs.
- Market Expansion: International growth and new service lines offer additional revenue opportunities. CI may capitalize on emerging markets and innovative products.
- Stable Dividend Policy: Consistent dividend payouts can attract long-term investors. The current dividend yield is seen as a stable income source.
More From Money Stockers:
- FMC Corporation Stock Forecast and price prediction (2025-2030)
- Nikola Corporation (NKLAQ) Stock Price Prediction and Analysis (2024–2030)
- Hims & Hers Health, Inc. (HIMS) Stock Price Prediction and Analysis (2024–2030)
- The Boeing Company (BA) Stock Price Prediction and Analysis (2024–2030)
- NTPC Stock Price Prediction and Analysis (2024–2030)
- Paylocity Holding Corporation (PCTY) Stock Forecast, Prediction (2025-2030)
5. Technical Analysis
Technical analysis provides a view of price movements and trends. It uses historical data to determine support, resistance, and future price behavior.
Moving Averages
Moving averages smooth out price fluctuations and reveal trends. For CI, the following averages are significant:
- 50-Day Moving Average: Currently at approximately $306.33. This average indicates a short-term trend.
- 200-Day Moving Average: Approximately $322.69. This shows a long-term trend that supports recent price movements.
Below is a table comparing these averages:
| Indicator | Value (USD) | Interpretation |
|---|---|---|
| 50-Day Moving Average | $306.33 | Indicates a short-term bullish trend |
| 200-Day Moving Average | $322.69 | Reflects overall long-term support level |
Momentum Indicators
Momentum indicators such as the Relative Strength Index (RSI) and MACD provide insight into price strength. CI’s RSI remains neutral, suggesting that the stock is not overbought or oversold. The MACD shows a gradual upward trend, confirming the stock’s momentum.
Key points include:
- RSI: Currently around 50. This indicates balanced buying and selling.
- MACD: Exhibits a rising trend. This supports the idea of gradual price increases.
The technical data supports the view that CI is in a steady phase with a slight upward drift.
Volatility Analysis
Volatility measures how much a stock’s price fluctuates. CI’s beta of 0.53 suggests lower volatility. This is favorable for conservative investors. A low beta means that the stock is less likely to experience large price swings.
A volatility table can help investors compare CI with market benchmarks:
| Metric | CI | Market (S&P 500) |
|---|---|---|
| Beta | 0.53 | 1.00 |
| Volatility | Low | Moderate |
The combination of stable moving averages, balanced momentum, and low volatility underpins CI’s technical outlook for both short and long-term investors.
Investment Potential & ROI Scenarios
Investors can evaluate CI based on different time horizons. The following sections present estimated return on investment (ROI) scenarios over short, medium, and long-term periods.
Short-Term Investment: 1 Month
For a one-month investment, technical analysis is paramount. The expected price range of $323.00 to $340.00 supports a modest gain. Investors should consider:
- Dividend Collection: The upcoming ex-dividend date on March 5, 2025, may add to returns.
- Price Momentum: Recent technical indicators suggest steady price movement.
An estimated ROI for a one-month period might be in the range of 2–4%. This is subject to market conditions and news events.
Medium-Term Investment: 1 Year
A one-year horizon takes into account earnings cycles and regulatory developments. With the projected revenue increase and positive technical outlook, CI may achieve a higher ROI. Analysts expect modest earnings growth. The medium-term ROI could range between 10–15%.
Key factors include:
- Earnings Growth: Analysts forecast an increase in EPS from 12.12 to around 30.49 in 2025.
- Stable Dividends: The dividend yield remains attractive.
- Sector Performance: The healthcare sector’s stability plays in CI’s favor.
Long-Term Investment: 5 Years (2030)
For a five-year investment, fundamental growth becomes critical. The long-term projections show steady revenue and EPS growth. The predicted price target for 2030 ranges between $405 and $420.
Investors may consider these factors:
- Demographic Shifts: Increased demand for healthcare services may drive growth.
- Regulatory Trends: Favorable policies could support future earnings.
- Innovation: Investments in technology and service expansion are expected to yield returns.
ROI for a long-term investment could be significantly higher. Based on the estimates, investors might see returns exceeding 40–50% over five years. These scenarios depend on continued performance and market conditions.
Monthly Forecast Breakdown (2025)
A month-by-month breakdown for 2025 helps investors monitor short-term fluctuations. Here is a forecast for select months.
March 2025
- Focus: Dividend impact and preparatory moves ahead of quarterly earnings.
- Forecast: Price expected to range between $325 and $335.
- Volume: Trading volumes may increase due to dividend-related buying.
- Technical Outlook: RSI near 50; 50-day moving average acting as support.
April 2025
- Focus: Pre-earnings positioning and market sentiment.
- Forecast: Prices likely to trade between $330 and $337.
- Volume: Steady trading expected as investors await May earnings.
- Technical Outlook: Moving averages provide clear support levels.
May 2025
- Focus: Earnings announcement scheduled for May 1, 2025.
- Forecast: Post-earnings adjustments could push prices between $335 and $345 if results meet expectations.
- Volume: A surge in trading is anticipated during and after earnings.
- Technical Outlook: MACD and RSI will be key in confirming trends.
November 2025
- Focus: Mid-cycle review and rebalancing by institutional investors.
- Forecast: Price levels may range from $340 to $350.
- Volume: Trading volumes might rise as analysts update forecasts.
- Technical Outlook: Long-term moving averages will be closely watched.
Each monthly segment is influenced by specific events. Investors should monitor news releases and earnings reports to adjust their strategies accordingly.
Risk Factors & Market Dynamics
Investors must be aware of potential risks that can affect CI’s stock performance. Both external and internal factors may influence the forecast.
External Risks
- Regulatory Environment: Changes in healthcare laws may affect the company’s revenue streams.
- Economic Conditions: A downturn in the economy could reduce consumer spending on healthcare.
- Market Competition: Increased competition from other healthcare insurers might pressure margins.
- Global Events: International economic and political developments may indirectly impact the stock.
Internal Risks
- Earnings Volatility: Fluctuations in EPS could cause unexpected price movements.
- Operational Challenges: Difficulties in integrating new services or technology may affect efficiency.
- Debt Levels: Although CI has a manageable debt load, any adverse change in capital structure could influence the stock.
- Management Decisions: Strategic missteps or delays in execution could have negative implications.
Investors should conduct their own research and review financial statements.
Historical Performance & Analyst Ratings
A review of CI’s historical performance and analyst recommendations provides context for future forecasts.
Historical Stock Price
The following table summarizes CI’s annual price movements over recent years:
| Year | Open (USD) | High (USD) | Low (USD) | Close (USD) | Change (%) | Volume |
|---|---|---|---|---|---|---|
| 2025 | 278.82 | 333.25 | 268.99 | 331.00 | +19.87% | 109,190,281 |
| 2024 | 301.29 | 370.83 | 262.03 | 276.14 | -7.78% | 407,857,970 |
| 2023 | 327.36 | 327.91 | 240.50 | 299.45 | -9.62% | 426,126,576 |
| 2022 | 229.49 | 340.11 | 213.16 | 331.34 | +44.29% | 450,218,319 |
| 2021 | 209.14 | 272.81 | 190.88 | 229.63 | +10.30% | 474,442,100 |
This table shows a mix of gains and corrections. The stock experienced significant growth in some periods. Short-term corrections provide buying opportunities for long-term investors.
Analyst Consensus
Sixteen analysts rate CI as “Strong Buy.” Their consensus is based on factors such as stable earnings, attractive dividend yield, and strong market positioning. The average 12-month price target is $380.06. Below is a summary of the analyst recommendations:
| Rating | Count | Price Target Range (USD) |
|---|---|---|
| Strong Buy | 5-6 | $350 to $410 |
| Buy | 10-11 | $330 to $394 |
| Hold | 1 | $340 (neutral) |
| Sell | 0 | N/A |
The average target indicates an expected upside of about 14.82% from the current price. Such consensus reflects strong confidence among market experts.
Frequently Asked Questions (FAQs)
Q1: What is the current market outlook for CI?
The market outlook is positive, supported by strong fundamentals and a “Strong Buy” rating from most analysts. The stock is projected to grow in both the short and long term.
Q2: What are the short-term price targets for CI?
In the next month, CI is expected to trade between $323 and $340. This is driven by technical support, dividend events, and approaching earnings reports.
Q3: What factors drive the long-term forecast for CI?
Key factors include steady revenue and EPS growth, favorable demographic trends, potential regulatory shifts, and strategic investments in technology and market expansion.
Q4: How does CI perform on technical indicators?
CI shows stable technical performance with a 50-day moving average near $306.33 and a 200-day moving average near $322.69. Momentum indicators, such as the MACD, confirm a gradual upward trend.
Q5: What are the main risks for CI investors?
Investors should consider external risks like regulatory changes and economic downturns, as well as internal risks like earnings volatility and operational challenges.
Conclusion
As a leader in healthcare insurance the Cigna Group keeps its position strong. CI shows strong financial performance with market indication readings that back up investor support throughout its positive market outlook. The market tells us CI shares will make small moves and dividend payments should increase value next week. The company expects better returns ahead because of their expected business expansions combined with population changes and investment plans.
Final Thoughts
People who want to invest in CI need to create a portfolio that includes different kinds of investments. The company’s business strengths match market sentiment and technical analysis which shows that CI is ready to grow in value. Healthcare industry demand for services does not change. Investors need to consider both market and regulatory changes in their decision-making. Look to trusted source reports regularly for better investment choices.
This analysis includes all available information about CI stock. The evaluation covers how the stock price behaves today plus its future growth potential along with chart patterns and threats. Through their analysis investors gain clearer insights into CI stock’s worth.